Larimar Therapeutics, Inc. Share Price & Technical Analysis
LRMR · $3.22 (+0.63%)
Healthcare / Biotechnology
$3.22
+0.63%
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
Price chart
Seasonality
Jun has 1 positive and 4 negative years (last 5 years shown)
-9% return in Jun, -2% avg return in past 3 year Jun month.
2% return in 2026, 34% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -8% | 51% | -10% | -11% | -12% | -9% | – | – | – | – | – | – | 2% |
| 25 | -5% | -19% | -27% | 29% | -19% | 26% | 21% | 3% | -14% | 22% | -10% | 9% | 16% |
| 24 | 29% | 102% | -34% | -8% | 16% | -15% | 17% | -6% | -15% | 26% | -23% | -38% | 49% |
| 23 | 17% | 24% | -30% | 4% | -23% | -16% | 39% | -12% | 5% | -26% | 17% | 35% | 36% |
| 22 | -8% | -55% | -5% | -7% | -30% | -20% | -10% | 42% | 19% | 3% | -3% | 28% | -47% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$346.96M
P/E ratio
—
52W high
$6.42
52W low
$2.22
Volume
13,38,835
Beta
0.91
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Larimar Therapeutics, Inc. share price today?
- Larimar Therapeutics, Inc. (LRMR) last traded around $3.22 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LRMR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LRMR. Download the app for real-time alerts.
- How can I analyze Larimar Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.